SummaryThe efficiency of the treatment of leukemia in children must be evaluated taking into account the percentage of total remissions and their duration.According to these criteria, there is a significant statistical difference between three groups of patients treated at three distinct periods by a different treatment.The best results were obtained by the association of prednisone and 6-mer-captopurine, the last drug being administered during remission as a maintenance treatment.